✦ LIBER ✦

Duloxetine for major depressive episodes in the course of psychotic disorders: A prospective clinical trial

✍ Scribed by S. Englisch; U. Knopf; B. Scharnholz; A. Kuwilsky; M. Deuschle; M. Zink

Book ID: 118439612
Publisher: Elsevier Science
Year: 2008
Tongue: French
Weight: 40 KB
Volume: 23
Category: Article
ISSN: 0924-9338
DOI: 10.1016/j.eurpsy.2008.01.780

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of genetic models for respons

Evaluation of genetic models for response in a randomized clinical trial of duloxetine in major depressive disorder

✍ John P. Houston; Wei Zou; Virginie Aris; Bonnie Fijal; Peining Chen; Alexandra N 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Variation in Catechol-O-Methyltransferas

Variation in Catechol-O-Methyltransferase Is Associated with Duloxetine Response in a Clinical Trial for Major Depressive Disorder

✍ Roy H. Perlis; Bonnie Fijal; David H. Adams; Virginia K. Sutton; Madhukar H. Tri 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 955 KB

Duloxetine in the treatment of major dep

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

✍ D.G.S. Perahia; F. Wang; C.H. Mallinckrodt; D.J. Walker; M.J. Detke 📂 Article 📅 2006 🏛 Elsevier Science 🌐 French ⚖ 568 KB

Escitalopram and duloxetine in the treat

Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials

✍ Lam, Raymond W.; Andersen, Henning F.; Wade, Alan G. 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 84 KB

Duloxetine in the acute and long-term tr

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

✍ Michael J. Detke; Curtis G. Wiltse; Craig H. Mallinckrodt; Robert K. McNamara; M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Safety and tolerability of duloxetine in

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials

✍ James I. Hudson; Madelaine M. Wohlreich; Daniel K. Kajdasz; Craig H. Mallinckrod 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

## Abstract ## Objective To examine the safety and tolerability of the antidepressant duloxetine across multiple studies for major depressive disorder (MDD). ## Method Safety data were integrated from the acute phases of eight double‐blind, placebo‐controlled trials in which patients were random